[1] Hunter DJ, Bierma-Zeinstra S. Osteoarthritis. Lancet 2019;393(10182):1745-59.
[2] Sandell LJ, Aigner T. Articular cartilage and changes in arthritis. An introduction: cell biology of osteoarthritis. Arthritis research 2001;3(2):107-13.
[3] Liu-Bryan R, Terkeltaub R. Emerging regulators of the inflammatory process in osteoarthritis. Nature reviews Rheumatology 2015;11(1):35-44.
[4] Qin J, Shang L, Ping AS, Li J, Li XJ, Yu H, et al. TNF/TNFR signal transduction pathway-mediated anti-apoptosis and anti-inflammatory effects of sodium ferulate on IL-1beta-induced rat osteoarthritis chondrocytes in vitro. Arthritis research & therapy 2012;14(6):R242.
[5] Goldring MB. Update on the biology of the chondrocyte and new approaches to treating cartilage diseases. Best practice & research Clinical rheumatology 2006;20(5):1003-25.
[6] Kim HA, Blanco FJ. Cell death and apoptosis in osteoarthritic cartilage. Current drug targets 2007;8(2):333-45.
[7] Matyas JR, Adams ME, Huang D, Sandell LJ. Discoordinate gene expression of aggrecan and type II collagen in experimental osteoarthritis. Arthritis and rheumatism 1995;38(3):420-5.
[8] Bartel DP. MicroRNAs: target recognition and regulatory functions. Cell 2009;136(2):215-33.
[9] Nugent M. MicroRNAs: exploring new horizons in osteoarthritis. Osteoarthritis and cartilage 2016;24(4):573-80.
[10] Cong L, Zhu Y, Tu G. A bioinformatic analysis of microRNAs role in osteoarthritis. Osteoarthritis and cartilage 2017;25(8):1362-71.
[11] Yan L, Ma J, Zhu Y, Zan J, Wang Z, Ling L, et al. miR-24-3p promotes cell migration and proliferation in lung cancer by targeting SOX7. Journal of cellular biochemistry 2018;119(5):3989-98.
[12] Lin Y, Cao H, Tian Y, Yang X, Zhou C, Zhang Q. miR-24-3p stimulates migration, invasion and proliferation of prostate cancer cells by targeting suppressor of cytokine signaling 6. International journal of clinical and experimental pathology 2018;11(3):1803-10.
[13] Yu G, Jia Z, Dou Z. miR-24-3p regulates bladder cancer cell proliferation, migration, invasion and autophagy by targeting DEDD. Oncol Rep 2017;37(2):1123-31.
[14] Tan H, Qi J, Fan BY, Zhang J, Su FF, Wang HT. MicroRNA-24-3p Attenuates Myocardial Ischemia/Reperfusion Injury by Suppressing RIPK1 Expression in Mice. Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology 2018;51(1):46-62.
[15] Xiao X, Lu Z, Lin V, May A, Shaw DH, Wang Z, et al. MicroRNA miR-24-3p Reduces Apoptosis and Regulates Keap1-Nrf2 Pathway in Mouse Cardiomyocytes Responding to Ischemia/Reperfusion Injury. Oxidative medicine and cellular longevity 2018;2018:7042105.
[16] Shen A, Zheng D, Luo Y, Mou T, Chen Q, Huang Z, et al. MicroRNA-24-3p alleviates hepatic ischemia and reperfusion injury in mice through the repression of STING signaling. Biochem Biophys Res Commun 2020;522(1):47-52.
[17] Ragni E, Perucca Orfei C, De Luca P, Colombini A, Vigano M, de Girolamo L. Secreted Factors and EV-miRNAs Orchestrate the Healing Capacity of Adipose Mesenchymal Stem Cells for the Treatment of Knee Osteoarthritis. International journal of molecular sciences 2020;21(5).
[18] Scorilas A, Kyriakopoulou L, Yousef GM, Ashworth LK, Kwamie A, Diamandis EP. Molecular cloning, physical mapping, and expression analysis of a novel gene, BCL2L12, encoding a proline-rich protein with a highly conserved BH2 domain of the Bcl-2 family. Genomics 2001;72(2):217-21.
[19] Nakajima A, Nishimura K, Nakaima Y, Oh T, Noguchi S, Taniguchi T, et al. Cell type-dependent proapoptotic role of Bcl2L12 revealed by a mutation concomitant with the disruption of the juxtaposed Irf3 gene. Proceedings of the National Academy of Sciences of the United States of America 2009;106(30):12448-52.
[20] Li MG, Liu XY, Liu ZQ, Hong JY, Liu JQ, Zhou CJ, et al. Bcl2L12 Contributes to Th2-Biased Inflammation in the Intestinal Mucosa by Regulating CD4(+) T Cell Activities. Journal of immunology (Baltimore, Md : 1950) 2018;201(2):725-33.
[21] An YF, Wu YJ, Zeng XH, Song LJ, Ma F, Liao WJ, et al. B cell lymphoma-2-like protein-12 association with T-helper 2 inflammation in chronic rhinosinusitis with allergy. International forum of allergy & rhinology 2018;8(11):1300-7.
[22] Kourtis A, Adamopoulos PG, Papalois A, Iliopoulos DC, Babis GC, Scorilas A. Quantitative analysis and study of the mRNA expression levels of apoptotic genes BCL2, BAX and BCL2L12 in the articular cartilage of an animal model of osteoarthritis. Annals of translational medicine 2018;6(12):243.
[23] Altman R, Asch E, Bloch D, Bole G, Borenstein D, Brandt K, et al. Development of criteria for the classification and reporting of osteoarthritis. Classification of osteoarthritis of the knee. Diagnostic and Therapeutic Criteria Committee of the American Rheumatism Association. Arthritis and rheumatism 1986;29(8):1039-49.
[24] Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001;25(4):402-8.
[25] Chen Z, Liu M, Zhang W, Deng M, Zhou Y, Li Y. miR-24-3p induces human intervertebral disc degeneration by targeting insulin-like growth factor binding protein 5 and the ERK signaling pathway. Life sciences 2020;243:117288.
[26] Hwang SG, Ryu JH, Kim IC, Jho EH, Jung HC, Kim K, et al. Wnt-7a causes loss of differentiated phenotype and inhibits apoptosis of articular chondrocytes via different mechanisms. The Journal of biological chemistry 2004;279(25):26597-604.
[27] Kapoor M, Martel-Pelletier J, Lajeunesse D, Pelletier JP, Fahmi H. Role of proinflammatory cytokines in the pathophysiology of osteoarthritis. Nat Rev Rheumatol 2011;7(1):33-42.
[28] Komori T. Functions of the osteocyte network in the regulation of bone mass. Cell and tissue research 2013;352(2):191-8.
[29] Hoff P, Buttgereit F, Burmester GR, Jakstadt M, Gaber T, Andreas K, et al. Osteoarthritis synovial fluid activates pro-inflammatory cytokines in primary human chondrocytes. International orthopaedics 2013;37(1):145-51.
[30] Giotakis AI, Lazaris AC, Kataki A, Kontos CK, Giotakis EI. Positive BCL2L12 expression predicts favorable prognosis in patients with laryngeal squamous cell carcinoma. Cancer biomarkers : section A of Disease markers 2019;25(2):141-9.
[31] Tzovaras A, Kladi-Skandali A, Michaelidou K, Zografos GC, Missitzis I, Ardavanis A, et al. BCL2L12: a promising molecular prognostic biomarker in breast cancer. Clinical biochemistry 2014;47(18):257-62.
[32] Zhang S, Zhang Q, Shi G, Yin J. MiR-182-5p regulates BCL2L12 and BCL2 expression in acute myeloid leukemia as a potential therapeutic target. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie 2018;97:1189-94.